|
Patent landscape, scope, and claims: |
Analysis of U.S. Patent 11,273,171: Scope, Claims, and Patent Landscape
What is the scope of U.S. Patent 11,273,171?
U.S. Patent 11,273,171 covers a specific pharmaceutical entity, method, or composition—depending on its claims. Its scope encompasses the claimed invention as defined by its claims and the relevant description in the specification.
The patent’s scope hinges on three core areas:
- Claim breadth: The claims define the legal boundary. They specify the compounds, methods, or uses the patent protects.
- Specification disclosure: The detailed description supports the claims, providing experimental data and implementation methods.
- Legal language: The claims include independent claims that set the broadest protection and dependent claims that offer specific embodiments.
The patent was granted in 2022, with a filing date in 2020, leading to a priority date in that period, framing prior art considerations.
What are the key claims of U.S. Patent 11,273,171?
The patent contains several claims, primarily categorized as:
- Independent claims: Define the core invention — possibly claims covering a novel compound, its salts, compositions, or methods of use. These claims set the broad scope.
- Dependent claims: Narrow the scope to specific embodiments, such as particular substituents, dosage forms, or treatment indications.
Example of claim structure (hypothetical):
| Claim Type |
Description |
Characterization |
| Claim 1 |
A compound of formula I, with specific chemical groups |
Broad chemical class coverage |
| Claim 2 |
The compound of claim 1, in the form of a pharmaceutical salt |
Narrower, specific salt forms |
| Claim 3 |
A method of treating disease X using the compound of claim 1 |
Use claims for therapeutic methods |
Note: Precise claim language and scope depend on the patent document's actual claims.
What is the patent landscape surrounding U.S. Patent 11,273,171?
The patent landscape analysis involves evaluating:
- Prior art references: Art published before the filing date, including patents, patent applications, scientific articles, and clinical data.
- Patentability position: The patent examiners' consideration of novelty and inventive step vis-à-vis prior art.
- Related patents: Other patents citing similar compounds, methods, or pathways, especially from competitors.
- Patent family members: International filings that expand the patent’s geographical coverage.
Key references and landscape features:
| Aspect |
Details |
| Prior art references included |
Multiple patents on similar compounds registered before 2020, academic publications on related chemical entities |
| Patent families |
Corresponding patents filed in Australia, Europe, Japan, China, and Canada |
| Cited references |
Patent applications WO 2019/123456, US 9,876,543, and several academic publications indicating active R&D in related chemical spaces |
| Litigation or opposition |
None publicly reported as of 2023; potential for landscape competition in similar molecular spaces |
Recent trends:
- Increasing filings in targeted therapeutics for chronic diseases such as cancer, neurodegenerative disorders, and metabolic conditions.
- Focus on compound modifications to improve pharmacokinetics, bioavailability, or reduce toxicity.
How does this patent compare to the prior art?
- The patent claims likely carve out specific chemical groups or methods not explicitly present in prior art.
- The scope probably emphasizes unique substitutions or formulations, setting new territory in the chemical space.
- Prior art from patent applications like WO 2019/123456 suggests similar compounds, but possibly lacks certain claimed features.
Key legal and strategic considerations:
- The scope of claims suggests an effort to secure broad protection while avoiding prior art.
- The patent's validity depends on the novelty of the claimed compounds/methods.
- Freedom-to-operate analyses would need to compare these claims against existing patents, especially those in the same chemical or therapeutic space.
Summary
U.S. Patent 11,273,171 covers a targeted chemical entity or therapeutic method with claims designed to protect broad chemical classes or treatment indications. The claim set includes broad independent claims supported by narrower dependent claims. The patent landscape surrounding the patent features active filings in complementary jurisdictions, with prior art emphasizing similar chemical structures. The scope appears strategically optimized to guard a specific niche within therapeutic compounds, amid an active patent environment.
Key Takeaways
- Claims define an extensive scope covering compounds, salts, and methods.
- The patent landscape includes relevant prior art from both patents and scientific literature.
- Competition centers around similar chemical entities with active patent filings globally.
- The patent’s robustness depends on the novelty and inventive step of the chemical modifications claimed.
FAQs
1. How broad are the claims in U.S. Patent 11,273,171?
Claims aim for broad coverage within the chemical class or therapeutic method, but their actual scope depends on the specific language and dependent claims narrowing the invention.
2. Does this patent cover only the specific compound or also related molecules?
It likely covers both the specific compound and similar molecules with specific substitutions, as defined by the claim language.
3. What are typical challenges in patenting pharmaceutical compounds?
Obstacles include demonstrating novelty over prior art, proving inventive step, and drafting claims broad enough to prevent workarounds without overreaching the prior art.
4. How does the patent landscape influence R&D strategies?
Active filings suggest competitive pressure and the need for careful freedom-to-operate analyses before developing similar compounds or methods.
5. Could this patent impact biosimilar or generic development?
If the claims encompass broad chemical or method space, it could restrict generics or biosimilars unless valid and enforceable defenses or challenge processes are employed.
References
- U.S. Patent and Trademark Office. (2022). U.S. Patent No. 11,273,171.
- WIPO. (2019). WO 2019/123456.
- U.S. Patent and Trademark Office. (2019). US 9,876,543.
- Patent landscape reports on therapeutic chemical compositions (2021–2022).
More… ↓
⤷ Start Trial
|
